celebrating our 20th anniversary in 2018, ventas is an s&p; 500 company and leading real estate investment trust (reit). as the leading capital provider for healthcare real estate with more than $40 billion of investments under our belt, we own communities where patients and their families receive health and healing; where world class researchers discover treatments for disease; and where seniors live with dignity. our diverse property portfolio combines seniors housing, life science research and innovation centers, medical office buildings, health system complexes, and post-acute care facilities. thanks to our financial strength and liquidity, our stock and robust dividend provides secure retirement savings and income to pensioners, firefighters, teachers and individuals around the world. ventas takes our esg (environment, social & governance) commitments seriously, emphasizing strong corporate governance; encouraging community engagement through social and financial support to the co
Company profile
Ticker
VTR
Exchange
Website
CEO
Debra Cafaro
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
VENCOR INC, VENTAS INC
SEC CIK
Corporate docs
Subsidiaries
1425 Hunt Club, LLC • 1445 Hunt Club, LLC • 14851 Yorba Street, LLC • 200 Andrews, LLC • 2010 Union Limited Partnership • 311 South Sarah, LLC • 3737 Market Investment Fund, LLC • 4210 Duncan, LLC • 4220 Duncan Holding, LLC • 4220 Duncan, LLC ...
IRS number
611055020
VTR stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
24 Apr 24
ARS
2023 FY
Annual report to shareholders
2 Apr 24
DEFA14A
Additional proxy soliciting materials
2 Apr 24
DEF 14A
Definitive proxy
2 Apr 24
8-K
Ventas Appoints Theodore Bigman and Joe V. Rodriguez, Jr. to Board of Directors
4 Mar 24
8-K
Ventas Announces James D. Shelton Has Decided to Retire from Board
4 Mar 24
8-K
Ventas Prices Cdn$650 Million of 5.10% Senior Notes Due 2029
29 Feb 24
8-K
Entry into a Material Definitive Agreement
20 Feb 24
424B5
Prospectus supplement for primary offering
20 Feb 24
S-3ASR
Automatic shelf registration
20 Feb 24
Transcripts
VTR
Earnings call transcript
2023 Q4
15 Feb 24
VTR
Earnings call transcript
2023 Q3
3 Nov 23
VTR
Earnings call transcript
2023 Q2
4 Aug 23
VTR
Earnings call transcript
2023 Q1
9 May 23
VTR
Earnings call transcript
2022 Q4
10 Feb 23
VTR
Earnings call transcript
2022 Q3
4 Nov 22
VTR
Earnings call transcript
2022 Q2
5 Aug 22
VTR
Earnings call transcript
2022 Q1
6 May 22
VTR
Earnings call transcript
2021 Q4
18 Feb 22
VTR
Earnings call transcript
2021 Q3
5 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 491.75 mm | 491.75 mm | 491.75 mm | 491.75 mm | 491.75 mm | 491.75 mm |
Cash burn (monthly) | (no burn) | (no burn) | 25.60 mm | 7.14 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 176.96 mm | 49.37 mm | n/a | n/a |
Cash remaining | n/a | n/a | 314.79 mm | 442.38 mm | n/a | n/a |
Runway (months of cash) | n/a | n/a | 12.3 | 61.9 | n/a | n/a |
Institutional ownership, Q4 2023
70.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 518 |
Opened positions | 90 |
Closed positions | 171 |
Increased positions | 172 |
Reduced positions | 184 |
13F shares | Current |
---|---|
Total value | 13.37 tn |
Total shares | 285.48 mm |
Total puts | 74.10 k |
Total calls | 415.00 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 63.99 mm | $3.19 tn |
STT State Street | 28.51 mm | $1.43 tn |
FMR | 23.05 mm | $1.15 tn |
JPM JPMorgan Chase & Co. | 20.02 mm | $998.04 bn |
PFG Principal Financial Group Inc - Registered Shares | 19.81 mm | $987.46 bn |
APG Asset Management US | 17.08 mm | $851.15 bn |
Centersquare Investment Management | 7.00 mm | $349.07 bn |
LGEN Legal & General | 6.36 mm | $316.93 bn |
Dimensional Fund Advisors | 5.86 mm | $292.27 bn |
T. Rowe Price | 5.08 mm | $252.97 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Apr 24 | Maurice S Smith | Common Stock | Grant | Acquire A | No | No | 42.64 | 41.668 | 1.78 k | 16,604.11 |
18 Apr 24 | Maurice S Smith | Common Stock | Grant | Acquire A | No | No | 42.64 | 54.839 | 2.34 k | 16,562.442 |
18 Apr 24 | Shelton James D | Common Stock | Grant | Acquire A | No | No | 42.64 | 261.487 | 11.15 k | 72,422.789 |
18 Apr 24 | Sumit Roy | Common Stock | Grant | Acquire A | No | No | 42.64 | 41.668 | 1.78 k | 11,119.648 |
18 Apr 24 | Sumit Roy | Common Stock | Grant | Acquire A | No | No | 42.64 | 46.167 | 1.97 k | 11,077.98 |
18 Apr 24 | Joe Vasquez Jr. Rodriguez | Common Stock | Grant | Acquire A | No | No | 42.64 | 8.211 | 350.12 | 1,036.211 |
18 Apr 24 | Nader Marguerite M | Common Stock | Grant | Acquire A | No | No | 42.64 | 41.668 | 1.78 k | 14,372.936 |
News
(VTR) - Analyzing Ventas's Short Interest
29 Mar 24
Cracking The Code: Understanding Analyst Reviews For Ventas
18 Mar 24
Evercore ISI Group Upgrades Ventas to Outperform, Announces $50 Price Target
18 Mar 24
Key Takeaways From Ventas Analyst Ratings
26 Feb 24
Wells Fargo Downgrades Ventas to Equal-Weight, Announces $46 Price Target
26 Feb 24
Press releases
Ventas Closes Extended and Improved $2.75 Billion Unsecured Credit Facility
24 Apr 24
Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting
18 Apr 24
Ventas Announces First Quarter 2024 Earnings Release Date and Conference Call
3 Apr 24
Ventas Issues Business Update
1 Apr 24
Ventas Earns ENERGY STAR® Partner of the Year Sustained Excellence in Energy Management Award
26 Mar 24